Syndax Pharmaceuticals (SNDX) Amortizatization of Intangibles (2020 - 2026)

Syndax Pharmaceuticals' Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $862000.0 for Q1 2026.

• On a quarterly basis, Amortizatization of Intangibles fell 76.05% year-over-year to $862000.0 in Q1 2026; TTM through Mar 2026 was $8.0 million, a 39.48% decrease from a year earlier, with the FY2025 full-year figure at $10.8 million, down 20.16% from the prior year.
• Amortizatization of Intangibles declined to $862000.0 in Q1 2026 per SNDX's latest filing, from $1.5 million in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $4.0 million in Q1 2023 and bottomed at $53000.0 in Q1 2022.
• The 5-year median for Amortizatization of Intangibles is $3.1 million (2024), against an average of $2.5 million.
• Across the five-year window, Amortizatization of Intangibles jumped 7384.91% in 2023 and slumped 76.05% in 2026, its largest moves.
• Year by year, Amortizatization of Intangibles stood at $2.0 million in 2022, then surged by 70.81% to $3.5 million in 2023, then dropped by 15.0% to $2.9 million in 2024, then sank by 47.96% to $1.5 million in 2025, then tumbled by 43.66% to $862000.0 in 2026.
• Per Business Quant, the three latest SNDX Amortizatization of Intangibles figures stand at $862000.0 (Q1 2026), $1.5 million (Q4 2025), and $2.4 million (Q3 2025).